Metabotropic Glutamate Receptor 5 Is a Coreceptor for Alzheimer Aβ Oligomer Bound to Cellular Prion Protein

Um, Ji Won, Kaufman, Adam C., Kostylev, Mikhail, Heiss, Jacqueline K., Stagi, Massimiliano, Takahashi, Hideyuki, Kerrisk, Meghan E., Vortmeyer, Alexander +5 more·2013·Neuron

Cited by (581)

Items 101–200 of 581

  1. The function of the cellular prion protein in health and disease
    Joel C. Watts, Matthew E.C. Bourkas, Hamza Arshad · 2017 · Acta Neuropathologica
  2. Physico-Pathologic Mechanisms Involved in Neurodegeneration: Misfolded Protein-Plasma Membrane Interactions
    Amulya Nidhi Shrivastava, Anita C. Aperia, Ronald Melki, Antoine Triller · 2017 · Neuron
  3. Neural Glycosylphosphatidylinositol-Anchored Proteins in Synaptic Specification
    Ji Won Um, Jaewon Ko · 2017 · Trends in Cell Biology
  4. Calcium channelopathies and Alzheimer's disease: Insight into therapeutic success and failures
    Chakroborty, Shreaya, Stutzmann, Grace E. · 2014 · European Journal of Pharmacology
  5. Genetic Factors in Mammalian Prion Diseases
    Simon Mead, Sarah E. Lloyd, John Collinge · 2019 · Annual Review of Genetics
  6. Therapeutic potential of mGluR5 targeting in Alzheimer's disease
    Anil Kumar, Dinesh Kumar Dhull, Pooja Shree Mishra · 2015 · Frontiers in Neuroscience
  7. Cellular prion protein as a receptor for amyloid-β oligomers in Alzheimer's disease
    Santiago V. Salazar, Stephen M. Strittmatter · 2016 · Biochemical and Biophysical Research Communications
  8. Therapeutic Molecules and Endogenous Ligands Regulate the Interaction between Brain Cellular Prion Protein (PrPC) and Metabotropic Glutamate Receptor 5 (mGluR5)
    Laura T. Haas, Mikhail A. Kostylev, Stephen M. Strittmatter · 2014 · Journal of Biological Chemistry
  9. Repression of the eIF2α kinase PERK alleviates mGluR-LTD impairments in a mouse model of Alzheimer's disease
    Wenzhong Yang, Xueyan Zhou, Helena R. Zimmermann, Douglas R. Cavener, Eric Klann, Tao Ma · 2016 · Neurobiology of Aging
  10. Synaptotoxic Signaling by Amyloid Beta Oligomers in Alzheimer's Disease Through Prion Protein and mGluR5
    A. Harrison Brody, Stephen M. Strittmatter · 2017 · Advances in pharmacology
  11. Synaptic dysfunction in early phases of Alzheimer's Disease
    Silvia Pelucchi, Fabrizio Gardoni, Mónica Di Luca, Elena E. Marcello · 2022 · Handbook of clinical neurology
  12. mGluR5 antagonism increases autophagy and prevents disease progression in the zQ175 mouse model of Huntington’s disease
    Khaled S. Abd‐Elrahman, Alison Hamilton, Shaunessy R. Hutchinson, Fang Liu, Ryan Charles Russell, Stephen S. G. Ferguson · 2017 · Science Signaling
  13. Tau is required for progressive synaptic and memory deficits in a transgenic mouse model of α-synucleinopathy
    Balvindar Singh, Ana Covelo, Hector A. Martell-Martinez, Carmen Nanclares, Mathew A. Sherman, Emmanuel Okematti, Joyce P. Meints, Peter J. Teravskis, Christopher Gallardo, Alena V. Savonenko et al. · 2019 · Acta Neuropathologica
  14. Prion Protein as a Toxic Acceptor of Amyloid-β Oligomers
    Silvia A. Purro, Andrew J. Nicoll, John Collinge · 2017 · Biological Psychiatry
  15. EphA4 Activation of c-Abl Mediates Synaptic Loss and LTP Blockade Caused by Amyloid-β Oligomers
    Lina M. Vargas, Nancy R. Leal, Lisbell D. Estrada, Adrian González, Felipe G. Serrano, Katherine A. Araya, Katia Gysling, Nibaldo C. Inestrosa, Elena B. Pasquale, Alejandra R. Alvarez · 2014 · PLoS ONE
  16. Diverse functions of the prion protein – Does proteolytic processing hold the key?
    Luise Linsenmeier, Hermann C. Altmeppen, Sebastian Wetzel, Behnam Mohammadi, Paul Säftig, Markus Glatzel · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  17. Fyn Kinase Controls Tau Aggregation In Vivo
    Adam Briner, Jürgen Götz, Juan Carlos Polanco · 2020 · Cell Reports
  18. Early Life Stress and Epigenetics in Late-onset Alzheimer’s Dementia: A Systematic Review
    Erwin Lemche · 2018 · Current Genomics
  19. Posttraumatic Stress Disorder-Like Induction Elevates β-Amyloid Levels, Which Directly Activates Corticotropin-Releasing Factor Neurons to Exacerbate Stress Responses
    Justice, Nicholas J., Huang, Longwen, Tian, Jin-Bin, Cole, Allysa, Pruski, Melissa, Hunt, Albert J., Flores, Rene, Zhu, Michael X., Arenkiel, Benjamin R., Zheng, Hui · 2015 · The Journal of Neuroscience
  20. STIM2 protects hippocampal mushroom spines from amyloid synaptotoxicity
    Попугаева Елена Александровна, Ekaterina I. Pchitskaya, Anastasiya B. Speshilova, Sergey Alexandrov, Hua Zhang, О. Л. Власова, Безпрозванный Илья Борисович · 2015 · Molecular Neurodegeneration
  21. Alzheimer’s-like pathology in aging rhesus macaques: Unique opportunity to study the etiology and treatment of Alzheimer’s disease
    Arnsten, Amy F. T., Datta, Dibyadeep, Leslie, Shannon, Yang, Sheng-Tao, Wang, Min, Nairn, Angus C. · 2019 · Proceedings of the National Academy of Sciences
  22. Aβ oligomers induce pathophysiological mGluR5 signaling in Alzheimer’s disease model mice in a sex-selective manner
    Khaled S. Abd‐Elrahman, Awatif B. Albaker, Jéssica M. de Souza, Fabiola Mara Ribeiro, Michael G. Schlossmacher, Mario Tiberi, Alison Hamilton, Stephen S. G. Ferguson · 2020 · Science Signaling
  23. Amyloid precursor protein (APP) and amyloid β (Aβ) interact with cell adhesion molecules: Implications in Alzheimer’s disease and normal physiology
    Grant Pfundstein, Alexander G. Nikonenko, Vladimir Sytnyk · 2022 · Frontiers in Cell and Developmental Biology
  24. Masitinib for the treatment of mild to moderate Alzheimer’s disease
    Folch, Jaume, Petrov, Dmitry, Ettcheto, Miren, Pedrós, Ignacio, Abad, Sonia, Beas-Zarate, Carlos, Lazarowski, Alberto, Marin, Miguel, Olloquequi, Jordi, Auladell, Carme et al. · 2015 · Expert Review of Neurotherapeutics
  25. Alzheimer's Disease Risk Factor Pyk2 Mediates Amyloid-β-Induced Synaptic Dysfunction and Loss
    Salazar, Santiago V., Cox, Timothy O., Lee, Suho, Brody, A. Harrison, Chyung, Annabel S., Haas, Laura T., Strittmatter, Stephen M. · 2019 · The Journal of Neuroscience
  26. Neurotoxic β-amyloid oligomers cause mitochondrial dysfunction—the trigger for PANoptosis in neurons
    Xiangyuan Meng, Qi Song, Zinan Liu, Xinpeng Liu, Yujie Wang, Jinyu Liu · 2024 · Frontiers in Aging Neuroscience
  27. Oligomers of Amyloid β Prevent Physiological Activation of the Cellular Prion Protein-Metabotropic Glutamate Receptor 5 Complex by Glutamate in Alzheimer Disease
    Haas, Laura T., Strittmatter, Stephen M. · 2016 · Journal of Biological Chemistry
  28. Differential Membrane Binding and Seeding of Distinct α-Synuclein Fibrillar Polymorphs
    Amulya Nidhi Shrivastava, Luc Bousset, Marianne L. Renner, Virginie Redeker, Jimmy Savistchenko, Antoine Triller, Ronald Melki · 2020 · Biophysical Journal
  29. Molecular Mechanisms of Lithium Action: Switching the Light on Multiple Targets for Dementia Using Animal Models
    Fiona Kerr, Ivana Bjedov, Oyinkan Sofola-Adesakin · 2018 · Frontiers in Molecular Neuroscience
  30. Epilepsy and Alzheimer’s Disease: Potential mechanisms for an association
    Filippo Sean Giorgi, Luigi Francesco Saccaro, Carla Letizia Busceti, Francesca Biagioni, Francesco Fornai · 2020 · Brain Research Bulletin
  31. mGlu5negative allosteric modulators: a patent review (2013 - 2016)
    Kyle A. Emmitte · 2017 · Expert Opinion on Therapeutic Patents
  32. A Role for Dendritic mGluR5-Mediated Local Translation of Arc/Arg3.1 in MEF2-Dependent Synapse Elimination
    Julia R. Wilkerson, Nien‐Pei Tsai, Marina A. Maksimova, Hao Wu, Nicole P. Cabalo, Kristofer W. Loerwald, Jason B. Dictenberg, Jay R. Gibson, Kimberly M. Huber · 2014 · Cell Reports
  33. The microcirculation, the blood-brain barrier, and the neurovascular unit in health and Alzheimer disease: The aberrant pericyte is a central player
    Yasmin Amy Divecha, Sanketh Rampes, Sabine Tromp, Sevda Boyanova, Alice L. Fleckney, Mehmet Fidanboylu, Sarah Ann Thomas · 2025 · Pharmacological Reviews
  34. PRNP/prion protein regulates the secretion of exosomes modulating CAV1/caveolin-1-suppressed autophagy
    Marcos Vinícios Salles Dias, Bianca Luise Teixeira, Bruna Roz Rodrigues, Rita Sinigaglia‐Coimbra, Isabel Porto-Carreiro, Martín Roffé, Glaucia N. M. Hajj, Vilma Regina Martins · 2016 · Autophagy
  35. Prions activate a p38 MAPK synaptotoxic signaling pathway
    Cheng Fang, Bei Wu, Nhat T. T. Le, Thibaut Imberdis, Robert C.C. Mercer, David A. Harris · 2018 · PLoS Pathogens
  36. eEF2K inhibition blocks Aβ42 neurotoxicity by promoting an NRF2 antioxidant response
    Asad Jan, Brandon Jansonius, Alberto Delaidelli, Syam Prakash Somasekharan, Forum Bhanshali, Milène Vandal, Gian Luca Negri, Donald G. Moerman, Ian R. Mackenzie, Frédéric Calon et al. · 2016 · Acta Neuropathologica
  37. Posttranslational modification impact on the mechanism by which amyloid‐β induces synaptic dysfunction
    Katarzyna M. Grochowska, PingAn Yuanxiang, Julia Bär, Rajeev Raman, Gemma Navarro Brugal, Giriraj Sahu, Michaela Schweizer, Arthur F. Bikbaev, Stephan Schilling, Hans‐Ulrich Demuth et al. · 2017 · EMBO Reports
  38. Membrane Interactions and Toxicity by Misfolded Protein Oligomers
    Mario Gonzalez-Garcia, Giuliana Fusco, Alfonso De Simone · 2021 · Frontiers in Cell and Developmental Biology
  39. Noncanonical Metabotropic Glutamate Receptor 5 Signaling in Alzheimer's Disease
    Khaled S. Abd‐Elrahman, Stephen S. G. Ferguson · 2021 · The Annual Review of Pharmacology and Toxicology
  40. RETRACTED ARTICLE: Hippocampal neuronal cells that accumulate α-synuclein fragments are more vulnerable to Aβ oligomer toxicity via mGluR5 – implications for dementia with Lewy bodies
    Cassia Overk, Anna E. Cartier, Gideon M. Shaked, Edward M. Rockenstein, Kiren K. Ubhi, Brian J. Spencer, Diana L. Price, Christina Patrick, Paula Desplats, Eliezer Masliah · 2014 · Molecular Neurodegeneration · Retracted
  41. Glial Calcium Signalling in Alzheimer’s Disease
    Dmitry Lim, Virginia Ronco, Ambra A. Grolla, Alexei Verkhratsky, Armando A. Genazzani · 2014 · Reviews of physiology, biochemistry and pharmacology
  42. Neuronal stress signaling and eIF2α phosphorylation as molecular links between Alzheimer's disease and diabetes
    Mychael V. Lourenco, Sergio Teixeira Ferreira, Fernanda G. De Felice · 2015 · Progress in Neurobiology
  43. Glutamate receptors function as scaffolds for the regulation of β-amyloid and cellular prion protein signaling complexes
    Alison Hamilton, Gerald Werner Zamponi, Stephen S. G. Ferguson · 2015 · Molecular Brain
  44. The impact of metabotropic glutamate receptors into active neurodegenerative processes: A “dark side” in the development of new symptomatic treatments for neurologic and psychiatric disorders
    Valeria Bruno, Filippo Caraci, Agata Copani, Francesco Matrisciano, Ferdinando Nicoletti, Giuseppe Battaglia · 2016 · Neuropharmacology
  45. Genetic susceptibility to infectious diseases: Current status and future perspectives from genome-wide approaches
    Alessandra Mozzi, Chiara Pontremoli, Manuela Sironi · 2017 · Infection Genetics and Evolution
  46. Fyn kinase inhibition reduces protein aggregation, increases synapse density and improves memory in transgenic and traumatic Tauopathy
    Si Jie Tang, Arman Fesharaki‐Zadeh, Hideyuki Takahashi, Sarah Helena Nies, Levi M. Smith, Anin Luo, Annabel S. Chyung, Marius Chiasseu, Stephen M. Strittmatter · 2020 · Acta Neuropathologica Communications
  47. Hippocampal metabotropic glutamate receptor long‐term depression in health and disease: focus on mitogen‐activated protein kinase pathways
    Thomas M. Sanderson, Ellen L. Hogg, Graham L. Collingridge, Sônia A. L. Corrêa · 2016 · Journal of Neurochemistry
  48. The Role of P2X7 Receptor in Alzheimer’s Disease
    Linda Francistiová, Carolina Bianchi, Caterina Di Lauro, Álvaro Sebastián‐Serrano, Laura de Diego-García, Julianna Kobolák, András Dinnyés, Miguel Dı́az-Hernández · 2020 · Frontiers in Molecular Neuroscience
  49. Cellular prion protein and NMDA receptor modulation: protecting against excitotoxicity
    Stefanie A. G. Black, Peter K. Stys, Gerald Werner Zamponi, Shigeki Tsutsui · 2014 · Frontiers in Cell and Developmental Biology
  50. Regulation of Amyloid β Oligomer Binding to Neurons and Neurotoxicity by the Prion Protein-mGluR5 Complex
    Flávio H. Beraldo, Valeriy G. Ostapchenko, Fabiana A. Caetano, André Luiz Sena Guimarães, Giulia D. S. Ferretti, Nathalie Daude, Lisa N. Bertram, Katiane de Oliveira Pinto Coelho Nogueira, Jerson Lima Silva, David A. Westaway et al. · 2016 · Journal of Biological Chemistry
  51. Neurotoxic Agent-Induced Injury in Neurodegenerative Disease Model: Focus on Involvement of Glutamate Receptors
    Md. Jakaria, Shin‐Young Park, Md. Ezazul Haque, Govindarajan Karthivashan, In‐Su Kim, Palanivel Ganesan, Dong‐Kug Choi · 2018 · Frontiers in Molecular Neuroscience
  52. Activity of translation regulator eukaryotic elongation factor-2 kinase is increased in Parkinson disease brain and its inhibition reduces alpha synuclein toxicity
    Asad Jan, Brandon Jansonius, Alberto Delaidelli, Forum Bhanshali, Yi Andy An, Nelson Ferreira, Lisa M. Smits, Gian Luca Negri, Jens Christian Schwamborn, Poul Henning Jensen et al. · 2018 · Acta Neuropathologica Communications
  53. Beyond the Ligand: Extracellular and Transcellular G Protein–Coupled Receptor Complexes in Physiology and Pharmacology
    Henry A. Dunn, Cesare Orlandi, Kirill A. Martemyanov · 2019 · Pharmacological Reviews
  54. PET imaging of mGluR5 in Alzheimer’s disease
    Adam P. Mecca, Julia W. McDonald, Hannah R. Michalak, Tyler A. Godek, Joanna E. Harris, Erika Pugh, Emily C. Kemp, Ming-Kai Chen, Arash Salardini, Nabeel Nabulsi et al. · 2020 · Alzheimer s Research & Therapy
  55. Treatment of Alzheimer’s Disease: The Legacy of the Cholinergic Hypothesis, Neuroplasticity, and Future Directions
    John Wesson Ashford · 2015 · Journal of Alzheimer s Disease
  56. Combining two repurposed drugs as a promising approach for Alzheimer's disease therapy
    Ilya M. Chumakov, Serguei Nabirotchkin, Nathalie Cholet, Aude Milet, Aurélie Boucard, Damien Toulorge, Yannick Pereira, Esther Graudens, Sory Traoré, Julie Foucquier et al. · 2015 · Scientific Reports
  57. Amyloid-β and Proinflammatory Cytokines Utilize a Prion Protein-Dependent Pathway to Activate NADPH Oxidase and Induce Cofilin-Actin Rods in Hippocampal Neurons
    Keifer P. Walsh, Laurie S. Minamide, Sarah J. Kane, Alisa E. Shaw, David R. Brown, Bruce E. Pulford, Mark D. Zabel, J. David Lambeth, Thomas B. Kuhn, James R. Bamburg · 2014 · PLoS ONE
  58. Amyloid Beta Oligomers Target to Extracellular and Intracellular Neuronal Synaptic Proteins in Alzheimer's Disease
    Yu Jie Ding, Jiahui Zhao, Xunle Zhang, Shanshan Wang, Kirsten L. Viola, Frances Elaine Chow, Yang Zhang, Carol Frances Lippa, William L. Klein, Yuesong Gong · 2019 · Frontiers in Neurology
  59. International Union of Basic and Clinical Pharmacology. CXI. Pharmacology, Signaling, and Physiology of Metabotropic Glutamate Receptors
    Karen J. Gregory, Cyril Goudet · 2020 · Pharmacological Reviews
  60. Studies of aging nonhuman primates illuminate the etiology of early‐stage Alzheimer's‐like neuropathology: An evolutionary perspective
    Amy F.T. Arnsten, Dibyadeep Datta, Todd M. Preuss · 2021 · American Journal of Primatology
  61. Neuron-specific regulation of class I PI3K catalytic subunits and their dysfunction in brain disorders
    Gross, Christina, Bassell, Gary J. · 2014 · Frontiers in Molecular Neuroscience
  62. The GPI-anchoring of PrP
    Berta Puig, Hermann C. Altmeppen, Markus Glatzel · 2014 · Prion
  63. Tau phosphorylation induced by severe closed head traumatic brain injury is linked to the cellular prion protein
    Richard Rubenstein, Binggong Chang, Natalia Grinkina, Eleanor Drummond, Peter Davies, Meir Ruditzky, Deep Raj Sharma, Kevin Wang, Thomas Wısnıewskı · 2017 · Acta Neuropathologica Communications
  64. Frontotemporal dementia mutant Tau promotes aberrant Fyn nanoclustering in hippocampal dendritic spines
    Pranesh Padmanabhan, Ramón Martínez‐Mármol, Di Xia, Jürgen Götz, Frédéric A. Meunier · 2019 · eLife
  65. Age-Dependent Long-Term Potentiation Deficits in the Prefrontal Cortex of theFmr1Knockout Mouse Model of Fragile X Syndrome
    Henry G. S. Martin, Olivier Lassalle, Jon T. Brown, Olivier J. Manzoni · 2015 · Cerebral Cortex
  66. Location-Dependent Signaling of the Group 1 Metabotropic Glutamate Receptor mGlu5
    Yuh-Jiin Ivy Jong, Ismail Sergin, Carolyn A. Purgert, Karen L. O’Malley · 2014 · Molecular Pharmacology
  67. Vitamin D: a custodian of cell signalling stability in health and disease
    Michael John Berridge · 2015 · Biochemical Society Transactions
  68. Super-resolution microscopy: a closer look at synaptic dysfunction in Alzheimer disease
    Pranesh Padmanabhan, Andrew Kneynsberg, Jürgen Götz · 2021 · Nature reviews. Neuroscience
  69. Differential Membrane Toxicity of Amyloid-β Fragments by Pore Forming Mechanisms
    Christian Peters, Denisse Bascuñán, Carlos Opazo, Luis Gerardo Aguayo · 2016 · Journal of Alzheimer s Disease
  70. Dietary arachidonic acid as a risk factor for age-associated neurodegenerative diseases: Potential mechanisms
    Mélanie H. Thomas, Sandra Pelleïeux, Nicolas Vitale, J L Olivier · 2016 · Biochimie
  71. Role of GPCR signaling and calcium dysregulation in Alzheimer's disease
    Sushma, Amal Chandra Mondal · 2019 · Molecular and Cellular Neuroscience
  72. Super-resolution microscopy reveals γ-secretase at both sides of the neuronal synapse
    Schedin-Weiss, Sophia, Caesar, Ina, Winblad, Bengt, Blom, Hans, Tjernberg, Lars O. · 2016 · Acta Neuropathologica Communications
  73. Synaptopathic mechanisms of neurodegeneration and dementia: Insights from Huntington’s disease
    Shiraz Tyebji, Anthony John Hannan · 2017 · Progress in Neurobiology
  74. Pyk2 Signaling through Graf1 and RhoA GTPase Is Required for Amyloid-β Oligomer-Triggered Synapse Loss
    Lee, Suho, Salazar, Santiago V., Cox, Timothy O., Strittmatter, Stephen M. · 2019 · The Journal of Neuroscience
  75. Metabotropic Glutamate Receptors in Alzheimer’s Disease Synaptic Dysfunction: Therapeutic Opportunities and Hope for the Future
    Akriti Srivastava, Brati Das, Annie Y. Yao, Riqiang Yan · 2020 · Journal of Alzheimer s Disease
  76. Roles for Arc in metabotropic glutamate receptor-dependent LTD and synapse elimination: Implications in health and disease
    Julia R. Wilkerson, Joseph P. Albanesi, Kimberly M. Huber · 2017 · Seminars in Cell and Developmental Biology
  77. Soluble Oligomers Require a Ganglioside to Trigger Neuronal Calcium Overload
    Roberta Cascella, Elisa Evangelisti, Alessandra Bigi, Matteo Becatti, Claudia Fiorillo, Massimo Stefani, Fabrizio Chiti, Cristina Cecchi · 2017 · Journal of Alzheimer s Disease
  78. Alzheimer's Aβ interacts with cellular prion protein inducing neuronal membrane damage and synaptotoxicity
    Christian Peters, María Paz Espinoza, Scarlet Gallegos, Carlos Opazo, Luis Gerardo Aguayo · 2014 · Neurobiology of Aging
  79. Aβ receptors specifically recognize molecular features displayed by fibril ends and neurotoxic oligomers
    Ladan Amin, David A. Harris · 2021 · Nature Communications
  80. Role of Liver X Receptor in AD Pathophysiology
    Adrián Gabriel Sandoval-Hernández, Luna Buitrago, Herman Moreno, Gloria Patricia Cardona‐Gómez, Gonzálo Arboleda · 2015 · PLoS ONE
  81. Structural and mechanistic aspects influencing the ADAM10-mediated shedding of the prion protein
    Luise Linsenmeier, Behnam Mohammadi, Sebastian Wetzel, Berta Puig, Walker S. Jackson, Alexander Hartmann, Keiji Uchiyama, Suehiro Sakaguchi, Kristina Endres, Jörg Tatzelt et al. · 2018 · Molecular Neurodegeneration
  82. Amyloid beta receptors responsible for neurotoxicity and cellular defects in Alzheimer’s disease
    Tae‐In Kam, Youngdae Gwon, Yong‐Keun Jung · 2014 · Cellular and Molecular Life Sciences
  83. Aβ42 oligomers selectively disrupt neuronal calcium release
    Cristian Lazzari, Maulilio John Kipanyula, Mario Agostini, Tullio Pozzan, Cristina Fasolato · 2014 · Neurobiology of Aging
  84. Conditional Deletion of Prnp Rescues Behavioral and Synaptic Deficits after Disease Onset in Transgenic Alzheimer's Disease
    Santiago V. Salazar, Christopher Gallardo, Adam C. Kaufman, Charlotte S. Herber, Laura T. Haas, Sophie Robinson, Jean C. Manson, Michael K. Lee, Stephen M. Strittmatter · 2017 · Journal of Neuroscience
  85. Tau acts as a mediator for<scp>A</scp>lzheimer's disease‐related synaptic deficits
    Liao, Dezhi, Miller, Eric C., Teravskis, Peter J. · 2014 · European Journal of Neuroscience
  86. The Binding Receptors of Aβ: an Alternative Therapeutic Target for Alzheimer’s Disease
    Min Xia, Xiaofang Cheng, Ruofan Yi, Dong Gao, Jiaxiang Xiong · 2014 · Molecular Neurobiology
  87. Cellular Prion Protein (PrPc): Putative Interacting Partners and Consequences of the Interaction
    Hajar Miranzadeh Mahabadi, Changiz Taghibiglou · 2020 · International Journal of Molecular Sciences
  88. Alzheimer’s Disease: A Molecular View of β-Amyloid Induced Morbific Events
    Rajmohamed Mohamed Asik, Natarajan Suganthy, Mohamed Asik Aarifa, Arvind Kumar, Krisztián Szigeti, Domokos Máthé, Balázs Zoltán Gulyás, Govindaraju Archunan, Parasuraman Padmanabhan · 2021 · Biomedicines
  89. Sigma-2 Receptors—From Basic Biology to Therapeutic Target: A Focus on Age-Related Degenerative Diseases
    Britney N. Lizama, Jennifer S. Kahle, Susan M. Catalano, Anthony O. Caggiano, Michael Grundman, Mary E. Hamby · 2023 · International Journal of Molecular Sciences
  90. Alzheimer disease: modeling an Aβ-centered biological network
    Dominique Campion, Cyril P. Pottier, Gaël Nicolas, Kilan Le Guennec, Anne Rovelet‐Lecrux · 2016 · Molecular Psychiatry
  91. Cytosolic calcium: Judge, jury and executioner of neurodegeneration in Alzheimer's disease and beyond
    Webber, Elise K., Fivaz, Marc, Stutzmann, Grace E., Griffioen, Gerard · 2023 · Alzheimer's &amp; Dementia
  92. Prion Protein: The Molecule of Many Forms and Faces
    Valerija Kovač, Vladka Čurin Šerbec · 2022 · International Journal of Molecular Sciences
  93. Amyloid-β oligomers interact with NMDA receptors containing GluN2B subunits and metabotropic glutamate receptor 1 in primary cortical neurons: Relevance to the synapse pathology of Alzheimer’s disease
    Kaori Taniguchi, Fumiko Yamamoto, Akiko Amano, Akira Tamaoka, Nobuo Sanjo, Takanori Yokota, Fuyuki Kametani, Wataru Araki · 2022 · Neuroscience Research
  94. Peptide regulation of cofilin activity in the CNS: A novel therapeutic approach for treatment of multiple neurological disorders
    Alisa E. Shaw, James R. Bamburg · 2017 · Pharmacology & Therapeutics
  95. Inhibition of group-I metabotropic glutamate receptors protects against prion toxicity
    Despoina Goniotaki, Asvin KK Lakkaraju, Amulya Nidhi Shrivastava, Pamela Bakirci, Silvia Sorce, Assunta Senatore, Rajlakshmi Marpakwar, Simone Hornemann, Fabrizio Gasparini, Antoine Triller et al. · 2017 · PLoS Pathogens
  96. Autophagy is increased following either pharmacological or genetic silencing of mGluR5 signaling in Alzheimer’s disease mouse models
    Khaled S. Abd‐Elrahman, Alison Hamilton, Maryam Vasefi, Stephen S. G. Ferguson · 2018 · Molecular Brain
  97. SEQUIN Multiscale Imaging of Mammalian Central Synapses Reveals Loss of Synaptic Connectivity Resulting from Diffuse Traumatic Brain Injury
    Andrew D. Sauerbeck, Mihika Gangolli, Sydney J. Reitz, Maverick H. Salyards, Samuel Kim, Christopher Hemingway, Maud Gratuze, Tejaswi Makkapati, Martin Kerschensteiner, David M. Holtzman et al. · 2020 · Neuron
  98. Regulation of microglia by glutamate and its signal pathway in neurodegenerative diseases
    Xinyue Zhang, Dan Wang, Bo Zhang, Jie Zhu, Zhulin Zhou, Li Cui · 2020 · Drug Discovery Today
  99. Group 1 Metabotropic Glutamate Receptors in Neurological and Psychiatric Diseases: Mechanisms and Prospective
    Li‐Da Su, Na Wang, Junhai Han, Ying Shen · 2021 · The Neuroscientist
  100. How the shapes of seeds can influence pathology
    Ronald Melki · 2017 · Neurobiology of Disease